U.S. Markets open in 6 hrs 20 mins
  • S&P Futures

    4,021.00
    +13.75 (+0.34%)
     
  • Dow Futures

    32,753.00
    +122.00 (+0.37%)
     
  • Nasdaq Futures

    12,829.50
    +41.00 (+0.32%)
     
  • Russell 2000 Futures

    1,776.80
    +9.50 (+0.54%)
     
  • Crude Oil

    72.97
    +0.16 (+0.22%)
     
  • Gold

    1,955.10
    +1.30 (+0.07%)
     
  • Silver

    23.06
    -0.09 (-0.37%)
     
  • EUR/USD

    1.0818
    +0.0014 (+0.1298%)
     
  • 10-Yr Bond

    3.5280
    0.0000 (0.00%)
     
  • Vix

    20.60
    -1.14 (-5.24%)
     
  • GBP/USD

    1.2327
    +0.0045 (+0.3661%)
     
  • USD/JPY

    130.9150
    -0.6400 (-0.4865%)
     
  • BTC-USD

    27,061.73
    -735.34 (-2.65%)
     
  • CMC Crypto 200

    589.59
    -17.86 (-2.94%)
     
  • FTSE 100

    7,471.77
    0.00 (0.00%)
     
  • Nikkei 225

    27,518.25
    +41.38 (+0.15%)
     

Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript

Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript

Additional information regarding these statements and our non-GAAP financial measures is available on our earnings release and in our SEC Form 10-K and 10-Q. To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva's 2022 results and business performance, recent events, and priorities going forward. Joining Richard and Eli on the call today is Sven Dethlefs, head of North America business, who will be available during the question-and-answer session that will follow the presentation.